Although genetic manipulation of pancreatic EGFR in mice leads to the acceleration or prevention of diabetes, the natural history of EGFR kinase activity during different phases of the progression to diabetes remains unknown [2,3,8,18]. The gene discussed is EGFR; the disease is diabetes mellitus.